Clinical trials recruiting in Bodø, Norway

Phase breakdown

Conditions recruiting in Bodø, Norway

Recruiting trials in Bodø, Norway

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
  NCT06966700 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
  NCT05211895 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
  NCT07312110 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• DESTINY Breast Respond HER2-(Ultra)Low Europe
  NCT05945732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Intraarticular Steroids, Saline and Occupational Therapy in People With CMC1 Osteoarthritis
  NCT06084364 · Phase: Phase 4 · Ages: 40 Years to 85 Years · Sex: All (male and female)
• Partial Breast Versus no Irradiation for Women With Early Breast Cancer
  NCT03646955 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: Female
• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
  NCT06697301 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
  NCT05634889 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Bodø, Norway?

10 recruiting trials have at least one study site in Bodø, Norway.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.